Antimicrobial resistance: Action by laboratories today for a cure tomorrow

Kanungo, R
July 2011
Indian Journal of Medical Microbiology;Jul2011, Vol. 29 Issue 3, p205
Academic Journal
The author reflects on the growing problem on drug resistant microorganisms. She mentions that the problem is rooted on limited diagnostics and lack of research, and argues that diagnostic tests for antibiotic resistance should be cost-effective, reliable, and timely. She adds that improvements on resistance detection, laboratory capacity optimization through networking, and training on quality control and standard procedure on laboratories to meet the national standard are important.


Related Articles

  • The microbes strike back. McGeer, Allison J.; Low, Donald E. // CMAJ: Canadian Medical Association Journal;12/15/97, Vol. 157 Issue 12, p1703 

    Describes issues related to the causes and prevalence of antimicrobial resistance. Such resistance a growing global problem; Reasons for resistance; Antimicrobial resistant pathogens in Canada mainly methicillin resistance in S. aureus infection (MRSA) and vancomycin-resistant enterococci...

  • Inadequate Antimicrobial Treatment: An Important Determinant of Outcome for Hospitalized Patients. Kollef, Marin H. // Clinical Infectious Diseases;9/1/2000 Supplement 3, Vol. 31, pS131 

    Discusses inadequate antimicrobial treatment as an important factor in the emergence of infections due to antibiotic-resistant bacteria. Factors that contribute to inadequate antimicrobial treatment of hospitalized patients; Strategies to minimize inadequate treatment; Use of empirical...

  • Immune Activation Efficacy of Indolicidin Is Enhanced upon Conjugation with Carbon Nanotubes and Gold Nanoparticles. Sur, Abhinav; Pradhan, Biswaranjan; Banerjee, Arka; Aich, Palok // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Antibiotic resistance is concern of today's world. Search for alternative molecules, for treatment and immune stimulation, remains at the forefront. One such group of biomolecules with promise, along the line of immune stimulation or therapy, is host defense peptide (HDP). These molecules,...

  • Antimicrobial resistance: No action today, no cure tomorrow. Sharma, A. // Indian Journal of Medical Microbiology;Apr2011, Vol. 29 Issue 2, p91 

    The author addresses the global spread of antimicrobial resistance. The author stresses that the growth of infections cuased by multi-drug resistance organisms risks jeopardizing health security and threatens the continued effectiveness of antimicrobials. The author also provides an overview of...

  • Consumer Antibacterial Soaps: Effective or Just Risky? Aiello, Allison E.; Larson, Elaine L.; Levy, Stuart B. // Clinical Infectious Diseases;9/1/2007 Supplement, Vol. 45, pS137 

    Background. Much has been written recently about the potential hazards versus benefits of antibacterial (biocide)—containing soaps. The purpose of this systematic literature review was to assess the studies that have examined the efficacy of products containing triclosan, compared with...

  • Monitoring Antimicrobial Use and Resistance: Comparison with a National Benchmark on Reducing Vancomycin Use and Vancomycin-Resistant Enterococci. Fridkin, Scott K.; Lawton, Rachel; Edwards, Jonathan R.; Tenover, Fred C.; McGowan Jr., John E.; Gaynes, Robert P. // Emerging Infectious Diseases;Jul2002, Vol. 8 Issue 7, p702 

    Focuses on a study which analyzed data from 50 intensive-care units at 20 U.S. hospitals reporting data on antimicrobial-resistant organisms and antimicrobial agent use, to determine if local monitoring data on vancomycin use directed quality improvement and decreased vancomycin-resistant...

  • Prevention of Resistance: A Goal for Dose Selection for Antimicrobial Agents. Drusano, G.L. // Clinical Infectious Diseases;1/15/2003 Supplement 1, Vol. 36, pS42 

    Drug-resistant microorganisms have become a major problem around the world. In nosocomial and community settings, many important pathogens have demonstrated high-grade resistance to many of our most important agents. In addition, the adverse impact of resistance has not been limited to the...

  • Antimicrobial resistance: Bacteria on the defence. Levy, Stuart B. // BMJ: British Medical Journal (International Edition);09/05/98, Vol. 317 Issue 7159, p612 

    Looks at antimicrobial resistance, focussing on the behavior of bacterial agents. Introduction of resistant bacteria from hospital; Results of studies of emerging resistant bacteria; Results of studies concerning resistance in bacteria.

  • Surveillance of antimicrobial resistance. Wale, Martin C.J. // BMJ: British Medical Journal (International Edition);09/05/98, Vol. 317 Issue 7159, p614 

    Looks at the surveillance of antimicrobial resistance, highlighting the gathering of data to approach the problem of antibiotic resistance. Results of centralised testing; Benefits of international cooperation on surveillance of resistance. INSET: A surveillance system for Europe.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics